comput
predict
immunogen
epitop
promis
platform
therapeut
prevent
vaccin
design
potenti
target
strategi
human
immunodefici
viru
despit
decad
effort
vaccin
avail
particular
therapeut
vaccin
devis
elimin
infect
cell
would
repres
key
compon
cure
strategi
hiv
peptid
design
base
individu
viroimmunolog
data
peopl
live
hivaid
recent
shown
abl
induc
posttherapi
viral
set
point
abat
howev
reproduc
scalabl
method
curtail
error
arbitrari
associ
manual
peptid
design
well
timeconsum
process
herein
introduc
custommun
userfriendli
web
tool
design
person
populationtarget
vaccin
appli
custommun
predict
person
epitop
use
patient
specif
human
leukocyt
antigen
hla
allel
viral
sequenc
well
expect
hlapeptid
bind
strength
potenti
immun
escap
mutat
note
custommun
predict
compar
favor
manual
design
peptid
administ
recent
phase
ii
clinic
trial
furthermor
util
custommun
design
prevent
vaccin
target
popul
highli
affect
result
allow
identif
peptid
tailor
popul
predict
elicit
tcell
immun
neutral
antibodi
structur
conserv
epitop
sever
acut
respiratori
syndrom
coronaviru
overal
data
describ
new
tool
rapid
develop
person
populationbas
immunotherapi
chronic
acut
viral
infect
al
pneumonia
outbreak
associ
new
coronaviru
probabl
bat
origin
natur
rapid
develop
autom
platform
data
gener
analysi
increasingli
make
precis
medicin
concret
option
sever
diseas
due
potenti
high
select
efficaci
immunotherapi
optim
choic
design
person
therapeut
intervent
effort
direct
focus
cancer
viral
infect
relev
applic
well
particularli
chronic
infect
character
extens
genet
divers
part
due
inhost
viral
evolut
human
immunodefici
viru
case
point
larg
number
circul
strain
high
replic
mutat
rate
hamper
develop
effect
vaccin
prevent
therapeut
sever
line
evid
highlight
relev
immun
control
infect
spontan
longterm
control
replic
accompani
presenc
broadli
neutral
antibodi
frequent
effect
cellmedi
immun
respons
moreov
protect
class
hla
allel
identifi
peopl
live
hivaid
plwha
macaqu
infect
hiv
homolog
simian
immunodefici
viru
siv
line
temporari
deplet
tcell
associ
rapid
viral
load
increas
replenish
revert
effect
therapeut
vaccin
base
cellmedi
immun
might
offer
advantag
decreas
number
infect
cell
one
hand
latent
infect
cell
constitut
main
barrier
cure
target
antiretrovir
drug
tcell
hand
effect
cellmedi
immun
respons
could
preserv
drugfre
control
infect
keep
viral
load
lowundetect
elimin
infect
cell
undergo
spontan
reactiv
latenc
therapeut
vaccin
could
also
combin
strategi
aim
purg
latent
reservoir
induc
pharmacolog
reactiv
latent
infect
cell
strong
correl
host
genet
background
immunemedi
control
infect
suggest
effect
immun
mainli
direct
subset
epitop
consist
sever
studi
shown
cellmedi
immun
respons
gag
protein
correl
lower
viral
load
plwha
posttherapi
control
infect
macaqu
peculiar
efficaci
antigag
immun
might
partial
explain
higher
fit
cost
associ
mutat
viral
protein
particular
specif
region
gag
essenti
packag
assembl
structur
evolutionarili
conserv
display
low
shannon
entropi
human
primat
lentivirus
howev
noteworthi
low
divers
suffici
per
se
induc
viral
load
control
vaccin
approach
design
exclus
select
epitop
base
evolutionari
conserv
shown
modest
effect
recent
phase
ii
clinic
trial
attempt
induc
antigag
immun
conserv
epitop
use
person
approach
base
patient
hla
sequenc
although
studi
enrol
small
number
plwha
test
multipl
intervent
preliminari
result
suggest
therapeut
vaccin
autolog
dendrit
cell
puls
individu
design
peptid
decreas
viral
set
point
patient
analyt
treatment
interrupt
ati
present
work
describ
test
new
autom
userfriendli
webbas
tool
design
person
peptid
vaccin
tool
name
custommun
princip
interrog
develop
therapeut
vaccin
candid
aim
intersect
input
data
patientspecif
viral
sequenc
hla
allel
custommun
provid
output
epitop
desir
length
filter
predict
specif
immunogen
mutat
potenti
note
simul
custommun
perform
superior
manual
vaccin
design
appli
clinic
trial
term
predict
clinic
respons
one
advantag
custommun
tradit
vaccin
design
techniqu
abil
quickli
adapt
tool
differ
target
strategi
regard
appli
custommun
novel
pandem
caus
sever
acut
respiratori
syndrom
coronaviru
due
acut
manifest
diseas
design
populationtarget
prevent
vaccin
chosen
practic
approach
compar
person
therapeut
vaccin
moreov
broaden
expect
coverag
increas
likelihood
achiev
herd
immun
strategi
abl
potenti
evok
neutral
antibodi
cellmedi
immun
prefer
use
input
region
identifi
viabl
target
custommun
abl
design
vaccin
candid
specif
region
preval
hla
genotyp
addit
custommun
select
hla
class
ii
restrict
epitop
could
induc
neutral
antibodi
thu
provid
twolay
protect
infect
taken
whole
result
show
potenti
custommun
algorithm
quickli
design
person
populationspecif
peptid
prevent
therapeut
vaccin
due
intuit
scalabl
approach
custommun
might
provid
effect
tool
rapid
vaccin
develop
chronic
acut
condit
custommun
web
tool
avail
http
wwwcustommunecom
written
python
http
wwwpythonorg
use
django
framework
http
wwwdjangoprojectcom
provid
user
easi
onlin
interfac
access
download
predict
dataset
without
code
knowledg
requir
tool
util
pipelin
figur
design
epitop
prevent
therapeut
vaccin
therapeut
vaccin
design
custommun
cross
input
data
patientspecif
viral
sequenc
dna
fasta
format
raw
dna
sequenc
input
patient
hlai
andor
hlaii
allel
provid
output
epitop
desir
kmer
length
facilit
allel
input
step
tool
provid
two
link
direct
user
list
support
class
class
ii
hla
allel
respect
list
mirror
netmhcpan
algorithm
either
hla
class
although
approach
could
potenti
extend
encompass
entir
sequenc
decid
limit
search
viabl
epitop
gag
gene
previous
describ
distinct
efficaci
antigag
cellmedi
immun
tool
pipelin
figur
start
translat
input
gag
genom
sequenc
protein
sequenc
custommun
perform
multipl
sequenc
align
use
clustal
omega
rest
web
servic
python
client
build
consensu
translat
sequenc
consensu
sequenc
use
predict
epitop
restrict
patientspecif
hlaallel
class
hlaspecif
epitop
provid
final
output
custommun
prefilt
algorithm
prefilt
follow
set
paramet
comput
epitop
affin
term
sequenc
variat
conserv
degre
allelerestrict
affin
previou
clinic
evid
immun
respons
figur
calcul
evolutionari
conserv
epitop
compar
term
similar
intern
databas
gag
amino
acid
sequenc
supplementari
file
collect
mainli
curat
align
retriev
lo
alamo
hiv
sequenc
databas
http
wwwhivlanlgov
moreov
verifi
whether
antigen
alreadi
report
candid
epitop
tool
compar
potenti
epitop
alreadi
describ
lo
alamo
hiv
immunolog
site
http
wwwhivlanlgovcontentimmunolog
refin
structur
assess
epitop
bind
hlaallel
custommun
perform
structur
epitop
model
follow
epitopehla
dock
determin
structur
stabil
hlapredict
epitop
bind
figur
custommun
pipelin
also
comput
relat
physicochem
paramet
person
epitop
sequenc
aid
assess
structur
stabil
candid
peptid
overal
tool
optim
identifi
immunogen
peptid
character
lowest
variabl
mutat
potenti
line
tool
specif
highlight
potenti
epitop
contain
region
previous
describ
essenti
viral
fit
novel
fundament
featur
approach
rna
virus
character
high
abil
mutat
custommun
pipelin
appli
vaccin
strategi
follow
parallel
workflow
figur
exampl
applic
acut
infect
case
approach
combin
neutral
antibodi
respons
recognit
hla
haplotyp
repres
given
popul
might
provid
reason
compromis
specif
scalabl
aim
use
custommun
identifi
potenti
neutral
epitop
overlap
epitop
consist
recognit
populationspecif
class
ii
hla
haplotyp
time
custommun
predict
anoth
set
epitop
optim
recognit
hla
class
haplotyp
popul
thu
provid
two
level
potenti
immun
recognit
overal
custommun
pipelin
provid
flexibl
fast
tool
gener
epitop
predict
accord
genet
divers
viru
genet
hla
profil
host
suscept
popul
test
custommun
predict
manual
epitop
select
use
result
ongo
multiintervent
phase
ii
clinic
trial
enrol
plwha
trial
autolog
dendrit
cell
puls
person
vaccin
design
manual
gag
sequenc
gener
circul
viru
studi
group
receiv
vaccin
along
intervent
patient
show
variabl
respons
includ
two
individu
display
signific
control
viral
load
ati
viral
hla
sequenc
patient
use
input
custommun
epitop
predict
tool
gener
display
overlap
administ
studi
figur
therefor
investig
potenti
therapeut
efficaci
custommun
predict
stratifi
patient
base
virolog
respons
ati
defin
viral
load
set
point
ie
differ
median
preand
posttherapi
copi
rnaml
plasma
note
nonrespond
patient
overlap
predict
epitop
calcul
custommun
administ
vivo
figur
convers
patient
administ
vaccin
epitop
highli
overlap
predict
custommun
character
higher
viral
load
abat
figur
data
suggest
custommun
predict
epitop
therapeut
potenti
could
improv
efficaci
speed
person
vaccin
design
ongo
outbreak
urgent
challeng
vaccin
develop
decid
test
potenti
custommun
rapid
identif
vaccin
target
order
util
custommun
predict
first
decid
identifi
viral
region
could
act
optim
input
tool
due
recent
evolut
equival
gag
ie
valid
viral
target
effect
immun
howev
share
approxim
sequenc
ident
sarscov
caus
agent
epidem
burst
acut
respiratori
distress
syndrom
ard
therefor
decid
use
previous
describ
strategi
success
target
sarscov
replic
templat
restrict
custommun
predict
particular
effort
direct
two
valid
subtarget
within
sglycoprotein
necessari
viral
attach
host
cell
portion
sglycoprotein
mediat
main
proteinprotein
interact
cellular
entri
receptor
ie
angiotensin
convert
enzym
describ
optim
target
neutral
antibodi
viral
sglycoprotein
region
bind
glycosyl
portion
interact
inhibit
pretreat
chloroquin
drug
recent
shown
effect
hamper
replic
vitro
patient
order
translat
approach
vaccin
design
perform
thorough
analysi
molecular
complex
viral
sglycoprotein
entri
receptor
consid
configur
superimpos
complex
state
receptor
ie
free
bound
case
competit
inhibitor
analys
indic
receptorbind
domain
rbd
surfac
sglycoprotein
interact
bound
configur
rel
smaller
though
overlap
interact
unbound
configur
figur
b
light
decid
restrict
custommun
input
rbd
sequenc
interact
bound
linker
amino
acid
henceforth
rbdp
figur
b
expect
approach
abl
evok
antibodi
rbdp
irrespect
boundunbound
configur
inspect
possibl
contribut
oligosaccharid
moieti
bind
interfac
oligosaccharid
moieti
describ
fundament
optim
bind
sglycoprotein
sarscov
far
publish
structur
partial
oligosaccharid
data
avail
therefor
decid
studi
phenomenon
analyz
publish
structur
inhibitorbound
present
nacetylglucosamin
nag
coval
bound
residu
remain
oligosaccharid
origin
attach
protein
evid
suggest
nag
present
structur
marker
posit
oligosaccharid
origin
attach
alter
crystal
process
superimpos
structur
structur
sglycoprotein
measur
atom
distanc
bind
interfac
nag
sglycoprotein
abl
determin
specif
segment
sglycoprotein
rbd
could
respons
interact
oligosaccharid
two
specif
residu
sglycoprotein
found
interact
nag
within
radiu
nag
ie
distanc
associ
signific
intermolecular
interact
figur
use
sglycoprotein
start
point
select
core
peptid
span
amino
acid
direct
translat
frame
led
identif
segment
sglycoprotein
rbd
henceforth
name
rbdg
bona
fide
target
vaccin
epitop
design
figur
note
structur
sglycoprotein
interact
pdb
recent
publish
present
report
prepar
author
conclud
bind
interfac
similar
sarscov
conclus
larg
overlap
result
present
analys
overal
evid
show
rbdp
rbdg
dna
sequenc
use
optim
input
custommun
mimic
approach
describ
first
analyz
variabl
rbdp
rbdg
multipl
align
sglycoprotein
sequenc
avail
ncbi
gisaid
includ
isol
human
bat
pangolin
supplementari
file
figur
line
predict
key
structur
role
rbdp
rbdg
sequenc
display
limit
variabl
mostli
deriv
nonhuman
isol
supplementari
file
moreov
everi
amino
acid
variant
except
one
rbdg
fulli
preserv
main
physicochem
characterist
consensu
residu
accord
score
system
result
suggest
rbdp
rbdg
repres
bona
fide
equival
conserv
gag
sequenc
use
privileg
target
custommun
predict
adapt
custommun
predict
popul
affect
pandem
time
analys
perform
retriev
rel
hla
allel
frequenc
individu
northern
itali
south
korea
supplementari
file
allel
frequenc
net
databas
http
wwwallelefrequenciesnet
moreov
appli
approach
hla
allel
individu
southern
china
citi
wuhan
outbreak
initi
spread
supplementari
file
rbdp
rbdg
sequenc
use
input
along
populationspecif
hla
custommun
return
set
epitop
supplementari
file
either
class
class
ii
hla
hla
class
ii
specif
epitop
filter
highlight
predict
target
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
neutral
antibodi
use
done
ensur
uniqu
peptid
may
provid
doubl
stimulu
necessari
optim
bcell
activ
antibodi
product
supplementari
file
line
custommun
pipelin
order
improv
likelihood
immun
recognit
bind
stabil
affin
promis
epitop
valid
molecular
dock
particular
epitop
select
dock
predict
bind
nm
hla
allel
describ
four
digit
resolut
popul
interest
allel
frequenc
net
databas
supplementari
file
figur
c
interestingli
identifi
epitop
includ
key
residu
involv
hydrogen
bond
format
sglycoprotein
eg
gln
epitop
steiyqagstpcngveg
epitop
lqsygfqp
epitop
irgdevrqiapgqtgkiadynyklpd
sglycoprotein
engag
respect
hydrogen
bond
residu
sinc
hydrogen
bond
recent
describ
crucial
stabil
virusreceptor
interact
epitop
contain
hydrogenbond
residu
might
particularli
suitabl
target
evok
immun
structur
determin
infect
moreov
order
ensur
best
coverag
likelihood
target
popul
also
includ
predict
epitop
preval
class
hla
antigen
result
show
peptid
set
specif
neutral
antibodyhla
class
ii
hla
class
could
provid
good
popul
coverag
upon
simultan
deliveri
potenti
achiev
herd
immun
fig
note
one
promis
epitop
candid
design
custommun
two
popul
examin
ie
epitop
klpddftgc
southern
chinawuhan
northern
itali
supplementari
file
figur
equival
highli
immunogen
peptid
previous
identifi
stimul
cell
patient
success
recov
sar
infect
taken
whole
result
show
applic
custommun
predict
epitop
specif
popul
highlight
set
vaccin
candid
curb
spread
highli
affect
area
precis
medicin
era
albeit
still
earli
stage
expect
supersed
tradit
onesizefitsal
therapeut
approach
develop
person
yet
scalabl
treatment
would
allow
account
genet
variabl
individu
pathogen
cancer
profil
pave
way
accur
efficaci
predict
reduc
side
effect
implement
custommun
pipelin
context
hivaid
show
tool
algorithm
may
use
predict
novel
immunebas
treatment
invivo
potenti
even
though
pipelin
appli
gag
protein
present
work
potenti
extend
hiv
genom
region
chronic
viral
infect
crucial
prerequir
person
custommun
approach
identif
key
structur
compon
target
pathogen
obtain
sequenc
data
host
hla
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
allel
infect
viru
cost
consider
might
repres
limit
factor
set
quick
advanc
sequenc
technolog
coupl
steep
reduct
price
make
approach
alreadi
feasibl
develop
countri
moreov
person
intervent
aim
cure
could
make
costbenefit
analysi
attract
also
develop
countri
often
bear
main
burden
chronic
viral
infect
term
potenti
efficaci
custommun
approach
reli
minim
epitop
divers
maxim
predict
bind
strength
immunogen
said
epitop
noteworthi
compar
real
clinic
scenario
epitop
predict
custommun
correl
treatment
respons
like
aid
larg
amount
immunolog
data
avail
eg
lo
alamo
hiv
immunolog
site
therefor
due
low
cost
scalabl
custommun
could
immedi
appli
design
therapeut
hiv
peptid
vaccin
autolog
dendrit
cell
vaccin
puls
tailor
gag
peptid
compar
previou
attempt
streamlin
vaccin
design
context
cancer
custommun
pipelin
includ
multipl
layer
epitop
rank
score
paramet
account
mutat
potenti
structur
conserv
hla
dock
escap
mutat
locat
neomut
previou
evid
antigen
partial
redund
filtrat
stage
envisag
maxim
chanc
durabl
potent
epitop
recognit
moreov
filter
predict
epitop
process
cleavag
includ
pipelin
manuscript
prepar
confirm
versatil
custommun
approach
implement
custommun
extend
includ
vaccin
design
current
predict
suggest
tradit
vaccin
strategi
might
slow
address
spread
pandem
mitig
death
toll
furthermor
immun
respons
develop
natur
infect
might
insuffici
provid
longterm
protect
reinfect
approach
herein
propos
aim
flexibl
respons
custom
popul
affect
given
time
novel
pathogen
necessarili
lack
wealth
immunolog
data
avail
heavili
studi
virus
like
vaccin
strategi
attempt
induct
cellmedi
immun
neutral
antibodi
inde
earli
evid
indic
broad
immun
respons
might
correl
success
clearanc
infect
custommun
predict
epitop
would
combin
broad
immun
stimul
design
base
common
hla
allel
popul
interest
potenti
provid
enough
immun
coverag
induct
herd
immun
moreov
choic
highli
conserv
viral
target
sourc
vaccin
epitop
ensur
broadli
effect
respons
individu
vaccin
prove
immunogen
util
custommun
whole
vaccin
design
process
last
less
work
day
therefor
approach
success
could
quickli
adopt
blunt
pandem
spread
ideal
preempt
bind
affin
predict
custommun
epitop
deriv
rbdp
rbdg
gener
higher
hla
class
allel
popul
consid
suffici
predict
cell
mediat
immun
would
preferenti
induc
propos
vaccin
previou
evid
mice
suggest
memori
tcell
might
alon
suffici
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
provid
effect
protect
sarscov
corrobor
hypothesi
one
peptid
design
custommun
equival
epitop
associ
clearanc
sarscov
infect
previou
epidem
immunogen
mice
use
vaccin
estim
probabl
reach
herd
immun
popul
consid
base
assumpt
develop
immun
respons
vaccin
peptid
would
per
se
suffici
guarante
level
protect
prerequisit
might
prove
optimist
noteworthi
viral
target
select
vaccin
design
ie
rbdp
rbdg
sglycoprotein
display
except
evolutionari
conserv
polymorph
region
detect
viral
isol
either
itali
south
korea
china
conserv
coupl
gener
moder
mutat
rate
sarscov
compar
rna
virus
yield
credibl
idea
achiev
protect
target
singl
immunodomin
epitop
moreov
expect
popul
coverag
vaccin
design
present
studi
theoret
suffici
achiev
herd
immun
base
estim
reproduct
number
current
work
simplifi
administr
schedul
increas
scalabl
envisag
among
possibl
strategi
synthes
one
multiepitop
peptid
target
popul
peptid
would
link
class
ii
hlarestrict
neutral
antibodi
epitop
well
class
hlarestrict
tcell
epitop
howev
approach
requir
empir
valid
could
modifi
eg
administ
hla
class
class
ii
restrict
epitop
separ
formul
reduc
immunogen
wellknown
caveat
epitopebas
vaccin
recent
advanc
adjuv
deliveri
technolog
might
allow
overcom
limit
apart
classic
adjuv
use
adjuv
drug
chloroquin
particular
interest
treatment
option
could
enhanc
vaccin
immunogen
possibl
provid
per
se
protect
viru
term
deliveri
carrier
liposom
nanoparticl
strategi
employ
chemic
conjug
cellpenetr
peptid
could
increas
epitop
present
antigen
present
cell
final
current
model
envisag
use
linker
sequenc
proteas
cleavag
site
differ
epitop
strategi
might
increas
chanc
present
peptid
optim
size
hla
allel
class
class
ii
howev
coval
linkag
epitop
also
describ
increas
immunogen
invivo
studi
requir
optim
strategi
induc
immun
due
ongo
rapid
expans
epidem
rel
good
safeti
profil
peptid
vaccin
pilot
clinic
test
significantli
affect
area
might
envisag
overal
studi
describ
novel
tool
improv
multiepitop
vaccin
design
specif
drastic
reduc
associ
time
cost
pipelin
herein
describ
directli
appli
test
person
therapeut
vaccin
identifi
core
epitop
prevent
vaccin
aim
popul
heavili
affect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
web
applic
custommun
avail
http
wwwcustommunecom
written
python
use
django
custommun
tool
provid
integr
pipelin
figur
predict
filtrat
person
epitop
biopython
packag
use
translat
input
sequenc
align
translat
sequenc
perform
use
python
client
clustal
omega
rest
web
servic
consensu
align
sequenc
gener
use
biopython
modul
similar
cutoff
biopython
proteinanalysi
function
use
estim
physicochem
paramet
secondari
structur
consensu
sequenc
includ
molecular
weight
graviti
specif
count
amino
acid
isoelectr
point
fraction
secondari
structur
custommun
connect
rest
interfac
iedbapi
serv
platform
use
netmhcpan
class
ii
hla
predict
well
bepipr
antibodi
epitop
predict
panda
packag
mckinney
et
al
use
structur
epitop
sort
tabl
allow
compar
filtrat
primari
filtrat
base
valu
cutoff
nm
use
prevent
loss
potenti
fals
neg
lo
alamo
hiv
databas
http
wwwhivlanlgovcontentimmunolog
use
creat
intern
hla
classspecif
dataset
previous
report
immunogen
epitop
hiv
gag
use
panda
highaffin
epitop
compar
dataset
highlight
epitop
previous
describ
immunogen
moreov
anoth
filtrat
layer
design
report
escap
variant
compar
epitop
intern
databas
collect
variou
literatur
sourc
includ
dataset
hlaassoci
polymorph
gag
report
ref
well
dataset
report
ref
dataset
epitop
variant
escap
mutat
report
lo
alamo
hiv
databas
http
wwwhivlanlgovcontentimmunolog
addit
filtrat
obtain
compar
epitop
locat
within
gag
sequenc
gag
region
essenti
viral
assembl
packag
tend
structur
evolutionarili
conserv
report
ref
refin
filtrat
custommun
comput
degre
conserv
epitop
compar
epitop
sequenc
hiv
sequenc
compendium
databas
includ
align
gag
protein
sequenc
degre
conserv
cscore
epitop
calcul
fraction
repres
subset
sequenc
epitop
score
local
align
use
clustal
omega
total
sequenc
intern
databas
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
next
layer
filtrat
select
epitop
rank
high
multipl
allel
case
multipleallel
input
select
user
hla
class
assess
impact
predict
mutat
custommun
comput
effect
mutat
retriev
intern
gag
sequenc
databas
supplementari
file
bind
affin
epitop
patient
hla
refin
analysi
perform
top
three
rank
epitop
initi
predict
tool
comput
affin
allel
user
estim
impact
mutat
specif
segment
affin
restrict
allel
degre
deviat
mutat
version
estim
base
calcul
standard
deviat
sd
set
valu
candid
epitop
mutant
version
deviat
valu
therefor
consid
neg
reflect
bind
stabil
peptid
segment
restrict
allel
respect
set
predict
mutant
version
segment
python
packag
peptidebuild
use
gener
model
top
epitop
packag
lightdock
implement
perform
epitopehla
dock
base
glowworm
swarm
optim
gso
algorithm
solv
structur
hla
allel
collect
databas
protein
data
bank
pdb
homolog
model
structur
unsolv
hla
allel
gener
use
swissmodel
distancesc
finit
idealga
refer
dfire
function
use
calcul
mean
forc
potenti
atom
residuespecif
manner
within
resolut
less
found
accur
predict
stabil
structur
hlaepitop
complex
dfire
implement
score
function
lightdock
simul
dock
score
ad
final
filtrat
layer
highest
rank
epitop
candid
highli
rank
epitop
candid
score
function
design
account
filtrat
layer
function
continu
paramet
repres
quantit
valu
accord
follow
rule
valu
rescal
calcul
reciproc
multipli
weight
factor
dock
score
preced
neg
sign
weight
neg
bind
energi
dfire
score
function
lightdock
cscore
consid
percentil
cscore
fraction
weight
factor
sdaffin
preced
neg
sign
weight
posit
valu
deviat
valu
categor
paramet
repres
binari
valu
weight
factor
favor
state
non
favor
state
given
null
valu
overal
formula
calcul
final
rank
calcul
follow
dfire
escapem
cscore
locationscor
sdaffin
doverlap
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
top
three
epitop
rank
score
analyz
base
possibl
overlap
epitop
data
set
previous
associ
postart
control
efficaci
vaccin
studi
lack
report
escap
mutat
final
predict
antibodi
epitop
estim
bepipr
report
overlap
top
candid
epitop
rank
score
allow
manual
inspect
result
sequenc
process
data
unfilt
predict
provid
separ
section
result
page
download
link
text
file
sglycoprotein
sequenc
retriev
ncbi
http
gisaid
multipl
align
perform
use
clustal
omega
web
servic
consensu
sequenc
sequenc
conserv
score
histogram
gener
jalview
v
accord
amino
acid
conserv
score
criteria
describ
class
ii
hla
allel
frequenc
retriev
allel
frequenc
net
databas
http
wwwallelefrequenciesnethlaasp
use
hla
classic
allel
freq
search
option
populationspecif
dataset
shown
supplementari
file
employ
identifi
repres
hla
allel
area
heavili
affect
spread
name
northern
itali
south
korea
china
wuhan
southern
china
allel
analyz
data
set
provid
valu
frequenc
determin
number
copi
given
allel
x
divid
total
number
allel
popul
size
n
assay
ie
frequenc
popul
interest
hla
allel
frequenc
least
one
dataset
popul
consid
analysi
given
hla
allel
repres
one
dataset
popul
weight
frequenc
calcul
specif
given
allel
interest
repres
n
dataset
popul
size
nn
frequenc
fn
weight
frequenc
fw
allel
calcul
dataset
employ
includ
hla
character
differ
resolut
allel
frequenc
consid
separ
case
digit
resolut
avail
supplementari
file
allel
digit
resolut
weight
frequenc
use
direct
input
custommun
allel
digit
resolut
weight
frequenc
instead
analyz
custommun
includ
potenti
second
field
option
current
support
custommun
class
class
ii
hla
allel
predict
custommun
bind
rbdp
rbdg
epitop
use
estim
potenti
vaccin
coverag
popul
interest
aim
weight
frequenc
hla
allel
avail
four
digit
resolut
popul
interest
includ
supplementari
file
moreov
among
allel
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
high
predict
bind
affin
nm
rbdp
rbdg
epitop
includ
vaccin
design
supplementari
file
estim
percentag
individu
p
given
popul
expect
carri
hla
allel
weight
frequenc
allel
f
popul
supplementari
file
use
accord
formula
heterodim
eg
overal
frequenc
heterodim
first
calcul
frequenc
heterodim
frequenc
heterodim
overal
heterodim
frequenc
use
calcul
p
describ
hla
allel
popul
predict
recogn
one
epitop
vaccin
consid
calcul
viral
load
individu
enrol
trial
measur
qpcr
describ
clinic
data
analyz
unpair
ttest
use
graphpad
prism
v
graphpad
softwar
la
jolla
california
usa
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
follow
filtrat
layer
custommun
identifi
whether
predict
epitop
display
highaffin
multipl
hla
allel
final
epitop
filtrat
discard
epitop
report
escap
mutat
andor
locat
evolutionari
conserv
region
affin
robust
among
remain
candid
custommun
restrict
analys
three
top
score
epitop
hla
class
custommun
comput
hla
bind
affin
potenti
mutant
version
though
classifi
escap
mutat
estim
impact
mutat
epitop
recognit
sdaffin
hlaepitop
dock
three
top
rank
epitop
custommun
comput
epitopehla
allel
dock
score
calcul
use
lightdock
python
packag
score
use
dfire
score
function
final
output
annot
parallel
process
bepipr
algorithm
implement
predict
neutral
antibodi
epitop
initi
consensu
sequenc
intersect
class
ii
restrict
epitop
increas
immunogen
final
output
class
ii
hla
custommun
rank
top
epitop
accord
score
custoscor
account
aforement
filtrat
paramet
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
twotail
student
ttest
panel
c
viral
load
set
point
trial
particip
receiv
peptid
high
low
overlap
custommun
predict
overlap
respect
viral
load
set
point
calcul
differ
preand
posttherapi
viral
load
set
point
posttherapi
viral
load
set
point
calcul
median
avail
measur
week
posttreat
interrupt
data
point
panel
b
c
indic
trial
particip
consensu
sequenc
evolutionari
conserv
calcul
base
multipl
sequenc
align
supplementari
file
use
jalview
conserv
score
base
b
exampl
epitopehla
dock
pose
gener
use
lightdock
custommunepredict
epitop
kiadynykl
magenta
shown
restrict
hla
class
histocompat
antigen
hlaa
green
highli
express
northern
itali
supplementari
file
also
shown
invari
cyan
dock
pose
score
use
dfire
function
list
supplementari
file
c
custommun
vaccin
predict
expect
coverag
target
popul
predict
epitop
select
dock
perform
supplementari
file
maximum
expect
popul
coverag
calcul
base
allel
frequenc
popul
list
supplementari
file
accord
formula
describ
materi
method
section
linker
region
vaccin
peptid
exampl
vaccin
strategi
base
singl
multiepitop
formul
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
r
rbdp
